Healthcare Sales & Marketing Network News: SABER-Bupivacaine

Searching News Database: SABER-Bupivacaine

HSMN NewsFeed - 22 Jun 2017
DURECT Completes Enrollment in PERSIST, Phase 3 trial for POSIMIR(R)
Biopharmaceuticals

HSMN NewsFeed - 20 Jun 2013
DURECT Announces FDA Acceptance of New Drug Application (NDA) Submission for POSIDUR(R) (SABER(R)-Bupivacaine)
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 27 Apr 2006
DURECT Provides an Update on Its Post-Operative Pain Depot (SABER(TM)-Bupivacaine) Program
Biopharmaceuticals

HSMN NewsFeed - 26 Jan 2006
DURECT to Expand Clinical Program to Additional Surgical Procedures and to Initiate U.S. Clinical Studies and for its Post-Operative Pain Relief Depot
Biopharmaceuticals Drug Delivery

Return to NewsFeed

Additional items found! 9

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 9 additional stories matching:
SABER-Bupivacaine
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.